US Patent Issued to THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY on Nov. 4 for "Blood-based signatures for diagnosis and sub-typing of inflammatory bowel disease subsets" (California Inventors)

ALEXANDRIA, Va., Nov. 6 -- United States Patent no. 12,461,101, issued on Nov. 4, was assigned to THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (Stanford, Calif.).

"Blood-based signatures for diagnosis and sub-typing of inflammatory bowel disease subsets" was invented by Samuel J. Rubin (Stanford, Calif.) and Aida Habtezion (Stanford, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "This disclosure provides a method for analyzing peripheral blood leukocytes. In some embodiments, method may comprise: (a) labeling peripheral blood leukocytes isolated from a patient that has or is suspected of having inflammatory bowel disease (IBD) with a panel of distinguishably-labeled antibodies and (b...